Early during rat thymus ontogeny, an important proportion of thymocytes expresses IL-2R and contains IL-2 mRNA. To investigate the role of the IL-2-IL-2R complex in rat T cell maturation, we supplied either recombinant rat IL-2 or blocking anti-CD25 mAb to rat fetal thymus organ cultures (FTOC) under several experimental conditions. The IL-2 treatment initially stimulated the growth of thymocytes and, as a result, induced T cell differentiation, but the continuous addition of IL-2 to rat FTOC, as well as the anti-CD25 administration, resulted in cell number decrease and inhibition of thymocyte maturation. These results indicate that immature rat thymocytes bear functional highaffinity IL-2R and that IL-2 promotes T cell differentiation as a consequence of its capacity to stimulate cell proliferation. Modifications in TCRαβ repertoire and increased numbers of NKR-P1 ⍣ cells, largely NK cells, were also observed in IL-2-treated FTOC. Furthermore, IL-2-responsiveness of different thymocyte subsets changed throughout thymic ontogeny. Immature CD4 -CD8 -cells responded to IL-2 in two stages, early in thymus development and around birth, in correlation with the maturation of two distinct waves of thymic cell progenitors. Mature CD8 ⍣ thymocytes maximally responded to IL-2 around birth, supporting a role for IL-2 in the increased proliferation of mature thymocytes observed in vivo in the perinatal period. Taken together, these findings support a role for IL-2 in rat T cell development.
Introduction
Mechanisms regulating T cell development remain largely unknown, but the relevance of developing thymocyte-thymic stromal cell component interactions, through cell-to-cell contacts or/and via soluble cell mediators, has been repeatedly recognized. IL-2, a potent growth factor for mature T cells, has also been pointed out as being involved in T cell development. Later results questioned, however, this possibility and the issue is currently a matter of discussion. Different pieces of evidence support the IL-2 requirement during T lymphopoiesis. (i) Individual chains (α, β and γ) of the IL-2R are expressed on immature thymocytes of mice, chickens and humans (1) (2) (3) , and, accordingly, the expression of functional high-affinity IL-2R has been reported on this thymic cell subset (1, 4, 5) . (ii) Murine immature CD3 -CD4 -CD8 -triple-negative (TN) cells produce IL-2 in vivo (6) and in vitro (7, 8) , and proliferate in its presence (1, 9, 10) . (iii) During fetal life, two waves of IL-2 mRNA production have been detected in the murine thymus, at the beginning of thymus ontogeny and around birth (11, 12) , in correlation with the development of two waves of T cell differentiation (13) (14) (15) . (iv) Culture of human and murine T cell precursors with IL-2 promotes their differentiation to TCRαβ, TCRγδ and NK cells (10, (16) (17) (18) . (v) In mice, profound modifications of T cell maturation can be induced by in vivo or in vitro treatments which alter the IL-2-IL-2R complex, including anti-IL-2R treatment (4, (19) (20) (21) , intoxication of high-affinity IL-2R-positive thymocytes with recombinant IL-2-diphteria toxin related fusion protein (5) , in excess IL-2 addition (22) (23) (24) and introduction of a transgenic human IL-2Rα chain that interferes with the expression of endogenous murine CD25 (25) . In contrast, Plum and De Smedt (26) were not able to block thymic development after anti-CD25 treatment of mouse organ cultures. Gene-disruption experiments also suggest that the IL-2-IL-2R complex is not required for the generation of normal cell populations in the mouse thymus (27) (28) (29) . Another argument against a role for IL-2 in governing T cell differentiation was the reported lack of IL-2R expression on immature rat thymocytes (30, 31) . Nevertheless, we conclusively showed, by both flow cytometry and immunohistochemistry, the expression of IL-2R on the thymus of 15-to 16-day-old fetal rats, when most thymocytes are immature TN cells (15) .
In the present study, the effects of both the addition of recombinant rat IL-2 and the blockade of IL-2R by anti-CD25 antibodies on T cell maturation are analyzed, using fetal thymus organ cultures (FTOC) established from 16-day-old embryonic rat lobes, in a further attempt to clarify the possible role of the IL-2-IL-2R complex in T cell development.
Methods

Animals
Wistar rats were maintained in our animal facilities. Rats were mated for a night and fetuses were removed at day 16 of gestation (date of finding of a vaginal plug was designated as day 0).
FTOC
Thymic lobes were aseptically removed from 16-day-old rat embryos using a stereoscopic microscope, trimmed of surrounding mesenchyme and organ-cultured as follows. Four to six individual thymic lobes were placed on the surface of 0.8 µm polycarbonate filters (Millipore Iberica, Madrid, Spain), which rested on stainless steel screen pieces attached to the central well of organ tissue culture dishes (Becton Dickinson, Mountain View, CA). Lobes were cultured in 1 ml of RPMI 1640 medium (2 mM L-glutamine) supplemented with sodium pyruvate (1 mM), streptomycin (100 µg/ml), penicillin (100 U/ ml) (all reagents: Gibco/BRL, Eragny, France) and 10% FCS (Biosys, Compiè gne, France). The peripheral well of culture dishes was filled with 5 ml of sterile distilled water. Cultures were incubated at 37°C in a humidified incubator containing 10% CO 2 in air. Medium was replaced daily. The control cultures were done as described and the IL-2-treated organ cultures were performed at a concentration of 20 U/ml of recombinant rat IL-2 (Serotec, Oxford, UK). The OX-39-treated cultures were carried out in complete medium supplemented with 50% culture supernatant from OX-39 hybridoma (mouse IgG1, anti-rat CD25). In this case, control cultures made in parallel were supplemented with 50% culture supernatant from an irrelevant hybridoma, OX-14 (mouse IgG1, antirat IgG2b). 
Immunofluorescence and flow cytometry
Cell cycle analysis
To determine the proportion of proliferating thymocytes, 1-2ϫ10 5 cells were fixed for 7 min in 70% ethanol at -20°C, washed in Tris-HCl buffer (pH 6.0), incubated with a RNase solution (1 mg/ml Tris-HCl) for 30 min at 37°C and resuspended in a solution of 0.05 mg/ml propidium iodide in PBS.
In some cases, cells were first stained with either CD8-FITC or TCRαβ-FITC antibodies, according to the above described protocol. Analysis was carried out in a FACScan, using Cell Fit and PC-Lysys software (Becton Dickinson)
In situ hybridization
Fetal thymocytes from day 16 of gestation were isolated, cytospun onto slides and fixed in paraformaldehyde (4% in PBS) for 30 min at room temperature. After permeabilization with proteinase K (2 µg/ml) in Tris-EDTA for 20 min at room temperature, cells were acetylated and dehydrated. Hybridization was carried out at 37°C in 5ϫSSC, 30% formamide, herring DNA (10 mg/ml), tRNA (10 mg/ml) and 5 µg/ml of a 168 bp digoxigenin-labeled cDNA probe for rat IL-2, synthesized by PCR amplification from a cloned cDNA with the specific primers 5Ј-AGC AAA AGC TTT CAC TTG GAA (297-317) and 3Ј-GAT GAT GCT TTG ACA GAT GGC (464-444) (kindly provided by Dr N. Barclay). Slides were washed in 30% formamide in 2ϫSSC at room temperature and 42°C for 5 and 15 min, respectively. Anti-digoxigenin antibodies conjugated to alkaline phosphatase (Boehringer Mannheim, Mannheim, Germany) were used for the immunological detection according to the commercial supplier's recommendations.
Results
Rat fetal thymocytes express IL-2R and IL-2 mRNA
Current data confirmed our previous results (15) demonstrating that the highest proportion of thymocytes which expressed IL-2Rα chain (20-30%) and contained IL-2 mRNA (20-25%) occurred on fetal day 16 ( Fig. 1) . At that stage, most thymocytes (90%) corresponded to immature CD3 -CD4 -CD8 -TN cells (Fig. 1A) . In addition, the phenotypical analysis of CD25 ϩ cell subset showed that 60-70% co-expressed both T cell markers CD2 and Thy-1 (Fig. 1B) .
Kinetics of rat fetal thymocyte development in organ culture
In terms of cell growth and acquisition of surface cell markers (i.e. CD4, CD8, TCRαβ), rat FTOC largely mimicked the in vivo T cell development during rat thymus ontogeny (15) . As reported in vivo, the cellularity of thymic lobes showed three periods of growth. A first increase (days 1-4) correlated well with high numbers of cycling cells (see Table 3 ). The cell number remained unchanged in those days of culture (days 5-7) equivalent to the in vivo perinatal period and then underwent a new increase, in correlation with a new wave of cycling cells (Table 1) . On the other hand, during the first 4 days of culture, there was a gradual decrease in the frequency of CD4 -CD8 -double-negative (DN) cells, in parallel with the appearance of immature CD4 -CD8 ϩ , CD4 ϩ CD8 ϩ doublepositive (DP), and mature CD4 ϩ CD8 -and CD4 -CD8 ϩ simplepositive (SP) thymocytes (Table 1 ). In the days of culture (5-7) equivalent to the in vivo perinatal period, a new signal of cell expansion promoted a transient increase of DN cells and, in the following days, their differentiation to immature CD4 -CD8 ϩ cells, DP and SP thymocytes (Table 1 ). In addition, the At each time point, organ-cultured thymocytes were double stained with FITC-anti-CD3 and PE-anti-CD25. CD3 -and CD3 high cell subpopulations were gated, and the proportion of CD25 ϩ cells in each subset was estimated. Results represent the mean percentages (and absolute numbers ϫ10 -3 ) of four to six independent experiments. frequency of CD25 ϩ cells in the most immature CD4 -CD8 -cell subset gradually decreased until day 4 of culture, sharply increasing, also in absolute numbers, during the above mentioned transient expansion of the DN cell compartment ( Table 2 ). The proportion of CD25-expressing cells in the CD3 high cell subset showed a gradual increase until day 12 of culture ( Table 2) .
Effects of the continuous presence of IL-2 in rat FTOC
The number of cells per thymic lobe increased (70%) after 1 day of treatment with IL-2, remaining unchanged at day 3 and diminishing (20-30%) after 5-7 days of culture. A new increase in the cell content occurred after one more week of culture in the presence of IL-2, then reaching higher numbers than those found in control FTOC ( Fig. 2A) . These variations correlated well with the changes in the frequency of proliferating cells, which only increased over control values after either 1 or 12 days of treatment with IL-2 (data not shown).
One day of treatment with IL-2 induced an increase in the proportion of DN cells (Fig. 2B ), although the absolute numbers of all cell subpopulations increased in the presence of IL-2, mainly those of both DN and CD4 ϩ CD8 -cells ( Fig. 2A) . Further analysis of these CD4 -CD8 -cells showed that most expressed CD2 (70-80%) and lacked CD3 expression (data Representative phenotypical profiles of thymocytes from control (left) and IL-2-treated (right) FTOC after labeling with FITC-anti-CD8 and PE-anti-CD4, days 1 and 12 (B); with FITC-anti-CD8 and PE-anti-TCRαβ, days 7 and 12 (C); or with FITC-anti-TCRγδ and PE-anti-CD8, day 7 (D). The proportions of thymocyte subsets defined according to TCRαβ expression (TCRαβ lo /TCRαβ hi ) were: (for control) 37.09%/10.95%, day 7, 51.65%/13.15%, day 12; and (for IL-2) 24.87%/22.01%, day 7, 29.87%/13.27%, day 12. The subpopulation of mature CD8 ϩ TCRαβ high thymocytes was gated as shown (C). not shown), indicating that they corresponded to early T cell precursors. The numbers of the different thymocyte subsets hardly changed at day 3 and decreased under control values, except for mature CD8 ϩ cells, after 5 days of treatment with IL-2 ( Fig. 2A) . By day 7 of culture, the number of DN cells again increased reaching control values, whereas that of mature CD8 ϩ thymocytes overcame them ( Fig. 2A and C) . After 12 days, IL-2 treatment induced an expansion affecting all thymic subsets, but mainly to DN cells ( Fig. 2A and B) . Accordingly, the proportion of cycling cells in the CD8 -cell subset increased on days 1 and 12 of culture and showed lower values in the rest of the culture period. The percentage of mature TCRαβ high cycling thymocytes was higher during the first week of treatment with IL-2 only to decrease under control values at day 12 (data not shown).
As shown in Fig. 2(C) , the percentage of TCRαβ ϩ cells only decreased after 12 days of treatment with IL-2, in agreement with the above-mentioned expansion of DN cells. The absolute numbers were, however, reduced throughout the culture period (day 5 C: 5.0ϫ10 4 , IL-2: 3.8ϫ10 4 ; day 7 C: 5.1ϫ10 4 , IL-2: 3.5ϫ10 4 ; day 12 C: 14.34ϫ10 4 , IL-2: 11.94ϫ10 4 ). On the other hand, the analysis of different TCR V α and TCR V β families in the mature TCRαβ high subpopulation revealed a preferential expansion of certain cell subsets when comparing 12 day control and IL-2-treated FTOC. The numbers of total TCRαβ high cells, as well as TCR V α 4 high and TCR V β 8.2 high cells, increased~25% in IL-2-treated cultures, whereas TCR V β 8.5 high and, mainly, TCR V β 16 high thymocytes exhibited higher increases (36 and 86% respectively). On the contrary, TCR V α 8 high and, principally, TCR V β 10 high cell subsets showed a much smaller expansion (11 and 3% respectively) than that of total TCRαβ high cell population.
A slight increase in the proportion of TCRγδ ϩ thymocytes was observed throughout the culture period in the presence of IL-2 (Fig. 2D) . The result was that, unlike TCRαβ cells, the number of TCRγδ thymocytes did not decrease in IL-2-treated FTOC (day 5 C: 4.8ϫ10 3 , IL-2: 4.5ϫ10 3 ; day 7 C: 7.8ϫ10 3 , IL-2: 7.3ϫ10 3 ), even increasing over control values by day 12 (C: 11.5ϫ10 3 , IL-2: 19.1ϫ10 3 ). Likewise, the CD8 -:CD8 ϩ TCRγδ cell ratio was not affected by the addition of IL-2 (Fig. 2D) .
Induction of NK cells in IL-2-treated lobes
To ascertain the nature of CD4 -CD8 -cells which accumulated in 12 day IL-2-treated FTOC, the proportion of cells expressing NKR-P1, a typical marker of rat NK cells (32), was analyzed. After IL-2 treatment, rat FTOC contained a higher proportion (20-30%) of NKR-P1 ϩ cells than control cultures (3-5%) (Fig. 3A) . However, the comparative phenotypical analysis of such a cell subpopulation from control and IL-2-treated cultures did not reveal remarkable differences (Fig. 3B) . In both cases, a small proportion of these cells expressed TCRαβ and CD5,~50-55% were CD2 ϩ , and mostly expressed Thy-1 antigen. A higher number of NKR-P1 ϩ cells expressed the IL-2Rα chain in IL-2-treated FTOC than in the control cultures. Additionally, only 30% of these cells expressed CD8 (Fig. 3B) , which indicates that 14-21% of the total thymic cell population corresponded to CD4 -CD8 -NKR-P1 ϩ cells in IL-2-treated FTOC. 
Effects of IL-2 treatment for 24 h
In order to evaluate the phenotype of IL-2-responding cells, as well as the possible variations in their response to IL-2 throughout thymic ontogeny, 16 day fetal thymus lobes were organ-cultured for 0, 3, 5, 7 and 11 days under control conditions, and then for an additional 24 h period with or without IL-2. In every experimental condition, the number of cells per thymic lobe increased after IL-2 addition, showing the highest increases at days 0 and 11 (ϩ1 and ϩ11ϩ1 conditions respectively) (Fig. 4) . DN cells responded to IL-2 at day 0 and from day 7 onwards, exhibiting minimal responses in the intermediate stages (Fig. 4) . Both CD8 ϩ TCRαβ ϩ/-and DP thymocytes also increased after IL-2 addition at days 0 and 11 (Fig. 4) . Mature CD4 -CD8 ϩ always responded to IL-2, exhibiting the maximal response at day 7, a time of culture equivalent to the first days of postnatal life (Fig. 4) . On the contrary, mature CD4 ϩ CD8 -thymocytes showed a minimal responsiveness to the addition of exogenous IL-2 (Fig. 4) . Accordingly, the increased number of CD4 ϩ cells observed at day 0, which lacked CD3 expression, corresponds to other cell types different from mature thymocytes, presumably macrophages. Finally, the numbers of TCRγδ thymocytes also increased in response to IL-2, mainly from day 7 onwards. Both CD8 -and CD8 ϩ TCRγδ subsets contributed to these increases (Fig. 4) .
Blockade of thymocyte maturation after OX-39 (anti-CD25) mAb administration to rat FTOC
The addition of OX-39 markedly inhibited the viable cell yield of rat FTOC (Fig. 5) . Accordingly, the proportion of total cycling cells was always lower in OX-39-treated FTOC than in control cultures (Table 3 ).
In the presence of OX-39, the maturation of first T cell precursors occurring in rat FTOC was only partially blocked (Fig. 5) , presumably because some of these precursor cells had already overcome the CD25 ϩ stage. As a consequence, reduced proportions of immature CD4 -CD8 ϩ , DP and mature SP thymocytes, together with increased percentages of DN cells, were observed in OX-39-treated FTOC (Fig. 6A) . Numbers of all thymocyte subsets were always lower than in control cultures (Fig. 5) , the DN cell subpopulation being the least affected by the treatment. In contrast, there was a total Asterisks refer to the statistical significance differences between control and IL-2-treated FTOC; * P ഛ 0.05, ** P ഛ 0.01, *** P ഛ 0.001. inhibition of the differentiation of the second wave of T cell progenitors (Fig. 5) , which led to a sharp increase in the proportion of CD4 -CD8 -cells at day 7, which remained constant by day 12 of treatment ( Fig. 6A and B) . The analysis of the frequency of proliferating cells in the CD8 -cell compartment showed lower values in OX-39-treated FTOC throughout the culture period (Table 3) . Nevertheless, at day 5, when the second wave of T cell maturation began to develop, the proportions of CD8 -cycling cells were similar in control and OX-39-treated cultures (Table 3) . This suggests that, presumably, the signal(s) of cell expansion triggering the second wave of T cell differentiation in control FTOC also took place in the presence of mAb OX-39.
Similar proportions of TCRγδ cells were found in control and OX-39-treated FTOC, which gradually increased during the first week of culture (day 3 C: 0.96%, OX-39: 1.23%; day 5 C: 4.96%, OX-39: 5.95% ; day 7 C: 9.19%, OX-39: 8.70%). After 12 days of treatment, the percentage of TCRγδ ϩ thymocytes remained constant (10.96%) due to blockade in the maturation pathway of TCRαβ cells and, accordingly, lower values (3.32%) were found in control FTOC. However, the reduction in the numbers of TCRγδ cells in OX-39-treated FTOC was 30% by day 3, 49% by day 5 and 80% by days 7-12. Furthermore, whereas CD8 ϩ TCRγδ thymocytes predominated in control cultures, a higher proportion of CD4 -CD8 -TCRγδ cells was detected after OX-39 addition (Fig. 6C) . 
Phenotypical characterization of CD4 -CD8 -cells from OX-39-treated FTOC
When analyzing the phenotype of the DN cell subset which appeared after 7 days of culture, it was clear that anti-CD25 treatment markedly increased the percentage of CD3 -CD4 -CD8 -early thymocytes. This was demonstrated by the small proportions of DN TCRαβ ϩ and TCRγδ ϩ found (Fig. 7) . In addition, the majority of DN cells from OX-39-treated FTOC expressed ICAM-1 (Fig. 7) . There was also a decreased proportion of CD2 ϩ cells, together with a slight increase in that of MHC class II ϩ , CD11b ϩ and CD68 ϩ cells (Fig. 7) , indicating the presence of slightly higher numbers of nonlymphoid cells. Accordingly, an ultrastructural study demonstrated that these cells largely corresponded to highly phagocytic macrophages (data not shown).
Effects of OX-39-treatment for 24 h
In general terms, the changes observed in rat FTOC after treatment with OX-39 mAb for 24 h were complementary to those found in IL-2-treated cultures under the same experimental conditions. In every stage analyzed, the cell content per thymic lobe decreased after OX-39 addition, the highest effects being at days 0 and 11 (ϩ1 and ϩ11ϩ1 conditions respectively), in agreement with the results obtained after IL-2 treatment (Fig. 8) . The numbers of DN cells always diminished in a similar proportion (40%) in OX-39-treated cultures, and those of both DP and CD8 ϩ TCRαβ ϩ/-thymocytes were affected on days 0 and 11 (Fig. 8) . Whereas the numbers of mature CD4 -CD8 ϩ thymocytes always decreased after OX-39 treatment, reaching the highest effects at day 7 in correlation with the above-mentioned results for IL-2-treated cultures, the reduction of mature CD4 ϩ CD8 -cells was similar in every tested condition (Fig. 8) . These results suggest that CD4 ϩ SP thymocytes, like DN cells, responded to IL-2 in an autocrine fashion. On the other hand, an important drop in TCRγδ thymocytes was also evident after culture with OX-39, the DN TCRγδ ϩ cell subset being the most affected by the anti-CD25 treatment (Fig. 8) .
Discussion
This study, extending our previous findings (15) , clearly indicates that IL-2 can play a role in rat T cell development. First, we confirm the presence of IL-2R ϩ thymocytes on 16-day-old rat embryos, when most thymocytes are immature TN cells. At this stage, this cell subset reaches its highest representation to diminish gradually until the perinatal period, when a new maximum is detected (15) . We describe the same developmental kinetics of CD25 ϩ immature thymocytes in rat FTOC, which is also similar to that reported in the embryonic thymus of mouse and chicken (2, 14) .
The expression of IL-2R on immature rat thymocytes has been a matter of discussion for years. In agreement with our results, Brocke et al. (33) found CD25-bearing cells in 16-day-old embryonic rat thymus. The authors misinterpreted, however, that these cells corresponded to mature thymocytes on the basis of the immunohistochemical detection of CD4 ϩ and/or CD8 ϩ cells in these thymic lobes. Obviously, these results reflect the cytoplasmic expression of those cell markers since, as we show by flow cytometry, on fetal day 16 most thymocytes are CD4 -CD8 -, some of which are progressing to the DP cell compartment. In contrast, other authors have failed to detect DN CD25 ϩ cells in rat fetal thymus (31) and Tackacs et al. (30) reported that IL-2Rα chain is expressed on a major proportion of adult DN cells only in one rat strain (F344) out the six tested. However, we have demonstrated the existence of DN CD25 ϩ cells in the adult thymus of Wistar, Lewis and Brown Norway rat strains (our unpublished results).
On the other hand, since thymocyte growth occurs in rat FTOC at concentrations of IL-2 (20 U/ml) which saturate high-, but not intermediate-, affinity receptors, and since proliferation and maturation are inhibited by the addition of anti-CD25 mAb, we conclude that early rat thymocytes bear functional high-affinity IL-2R. The same conclusion was reported by others in mice and humans (1, 4, 5) . Nevertheless, much controversy has arisen regarding the IL-2-induced proliferative responses of early thymocytes (1, 10, 17, 34, 35) , although most authors agree with the requirement of thymic stromal cells or an intact thymic microenvironment, as that provided by organ cultures, to the induction of the IL-2 pathway on immature thymocytes (4, 9, 17) .
Despite the initial cell expansion in rat FTOC, the continuous addition of IL-2 for the first week of culture inhibits thymocyte growth and αβ T cell differentiation, in agreement with previous results in mouse thymus organ cultures (22) (23) (24) . TCRγδ-expressing cells do not undergo numerical changes during this period in the presence of IL-2, as also described by Plum et al. (23) , while Waanders and Boyd (24) reported the blockade of both αβ and γδ T cell lineages. Furthermore, these inhibitory effects of IL-2 are dose dependent and reversible (data not shown and 24).The addition of IL-2 for five more days results, however, in a new cellular expansion affecting to all thymocyte subpopulations, basically due to the acquisition of IL-2 responsiveness by all thymic cell subsets in the presence of IL-2. Previously, IL-2-induced inhibitory effects on FTOC were addressed to a massive generation of LAK cells which would deplete thymocytes from organ cultures (22) . We cannot, however, correlate in time the decreased cellularity and inhibition of T cell maturation with the appearance of a significant number of NKR-P1 ϩ cells in our cultures. In agreement, Waanders and Boyd (24) documented the failure to detect any LAK cell activity against syngeneic thymocytes in IL-2-treated cultures. These authors also hypothesized that IL-2 inhibitory effects could be due to an arrest in differentiation of CD25 ϩ DN cells, as a consequence of a negative signaling through IL-2R, induced by the IL-2 concentrations used in these experiments, which are not continuously present in vivo during ontogeny. This hypothesis agrees with the decreased frequency of CD8 -cycling cells and the higher numbers of apoptotic cells (data not shown) observed in IL-2-treated FTOC. Zuñ iga-Pflü cker et al. (4) also reported that IL-2 addition to organ cultures induced thymocyte proliferation but the cell content did not change, indirectly indicating the occurrence of cell death. In fact, the inhibition of cell proliferation (36) and the induction of thymocyte apoptosis (37) have been reported after IL-2 treatment.
According to our results, the continuous addition of mAb OX-39 blocks cell proliferation and also thymocyte maturation, therefore suggesting that IL-2 promotes the differentiation of T cell precursors by inducing their proliferation. Supporting this, culture with IL-2 for 1 day induces an expansion of the DN cell subset which increases the absolute number, but not the percentage, of immature CD8 ϩ thymocytes. Likewise, Toribio et al. (16) showed that treatment of human pre-T cells with IL-2 only promoted their differentiation after a proliferative response developed, and Zuñ iga-Pflü cker and Kruisbeek (21) reported that anti-IL-2R treatment after sublethal irradiation slowed down thymocyte differentiation by first preventing the expansion of TN cells.
Another remarkable feature emerging from our results is the sharp accumulation of CD3 -CD4 -CD8 -cells which occurs in OX-39-treated cultures on day 7. Previously on day 5, the number of cycling CD8 -cells, which after anti-CD25 treatment is always under control values, notably increases. By this time a new wave of T cell maturation begins to develop in rat FTOC. However, in the presence of OX-39 these cells fail to differentiate into DP and SP mature thymocytes. The most likely interpretation of these findings is that the signal(s) triggering the second T cell differentiation wave occurs in both control and OX-39-treated thymic lobes, and this signal is not primarily IL-2, although its later involvement is clear. Accordingly, around birth, when a new precursor cell population begins to differentiate (13) (14) (15) , a peak of production of different cytokines, apart from IL-2, can be detected. These include IL-1, IL-4, IL-6, tumor necrosis factor-α and IFN-γ (12), known to stimulate the proliferation of early thymocytes (38, 39) .
We also analyze the phenotype of IL-2-responding cells throughout rat thymic ontogeny, showing that DN cells and SP mature thymocytes are the main cell targets for IL-2. The numbers of immature CD4 -CD8 ϩ and DP thymocytes basically change in the culture conditions ϩ1 and ϩ11ϩ1. In the first case, as a consequence of the proliferative stimulation (or blockade) on DN cells and on day 11 because all thymic cell subsets on rat FTOC acquire IL-2 responsiveness. The response of DN thymocytes to IL-2 occurs only in two stages, at the beginning of thymic development and around birth, in agreement with the development of two maturation waves of T cell precursors. After OX-39 treatment, however, the number of DN cells is reduced in a similar proportion in every culture condition, suggesting that this cell subset responds to IL-2 in an autocrine fashion, as previously reported (1) . On the other hand, it is important to clarify that among DN cells, CD3 -CD4 -CD8 -TN cells constitute the main IL-2-responding cell subset at the beginning of rat thymus ontogeny, while in later stages both TN cells and TCRγδ thymocytes contribute to the changes observed in the CD4 -CD8 -cell subpopulation.
In the mature thymocyte subpopulation, CD4 -CD8 ϩ , but not CD4 ϩ CD8 -, cells respond to the addition of exogenous IL-2. This distinct behavior of SP mature thymocytes to IL-2 has been pointed out by other authors and seems to be associated with a higher constitutive expression of IL-2Rβ chain on CD4 -CD8 ϩ thymocytes (3), as well as with the fact that CD4 ϩ T cells require complementary triggering signals to respond to IL-2 when IL-2R are expressed (40) . On the contrary, the response of CD4 ϩ thymocytes to the OX-39-dependent blockade could be attributed to the known ability of this cell subset for producing higher amounts of IL-2 than CD8 ϩ T cells (41) and their autocrine response to IL-2 (42) . With respect to CD4 ϩ CD8 -cells responding to IL-2 and OX-39 treatments 24 h after the establishment of rat FTOC, they lack CD3 expression and may represent macrophages, which weakly express this cell marker (43) and proliferate in the presence of IL-2 (44) . Supporting this, the numbers of macrophages and dendritic cells increase in 12 day IL-2-treated FTOC. Presumably, these non-lymphoid cells and their precursors, which express IL-2R (43, 45) , respond directly to the addition of IL-2, as suggested by the numerous dividing cells found in this cell population after IL-2 treatment (data not shown).
Remarkably, the response of mature CD8 ϩ thymocytes to either IL-2 or OX-39 mAb gradually increases to reach a maximum around birth. These results involve IL-2 as one of the growth factors governing the perinatal proliferation which increases the number of mature thymocytes just before migrating to colonize the peripheral lymphoid organs (15, 46) . Among mature TCRαβ high thymocytes, the analysis of different V α and V β families shows, after IL-2 treatment, slight changes in the proportions of TCR V β 8.5 and TCR V α 8 cells, and mainly a pronounced decrease in TCR V β 10 thymocytes parallel to an expansion of the TCR V β 16 cell subset. Other authors have reported modifications in the TCRγδ repertoire after culture with IL-2 (47, 48) . Furthermore, a patient suffering a variant of X chromosome-linked severe combined immunodeficiency (which affects the IL-2Rγ chain) exhibited, in agreement with our data, important variations in V β usage, V β 16 appearing underexpressed whereas V β 10 was overexpressed (49) . An IL-2-mediated expansion, secondary to selection, of specific TCR V α /V β -bearing cells which are induced to differentially express IL-2R could favor the proliferation of specific T cell clones, explaining these results.
Both CD8 -and CD8 ϩ γδ T cells respond to the addition of IL-2 and to the blockade by OX-39 mAb in rat FTOC. The expansion of TCRγδ-bearing cells in the presence of IL-2 has been previously demonstrated (4, 9, 47) . Recently, Leclercq et al. (50) reported, however, that in murine FTOC the γδ T cell population was affected by the administration of anti-IL-2Rβ chain, but not anti-IL-2Rα chain, mAb. The authors explained their results on the basis of a differential expression of IL-2R chains on the developing γδ thymocytes. Thus, immature TCRγδ low cells were IL-2Rα ϩ β -while TCRγδ high thymocytes expressed the β chain in the absence of the α chain. This pattern of development could be specific to mouse, because in rat (51) and chicken (2) IL-2Rα chain is expressed in both immature and mature γδ T cells.
The production of NK cells observed in our cultures maintained in the continuous presence of IL-2 confirms previous reports using different in vitro approaches (10, 17, (22) (23) (24) . The phenotype of NK cells generated in rat FTOC is similar to that described in IL-2-treated mouse FTOC (23) , although a small proportion of NKR-P1 ϩ cells co-expresses CD5 and TCRαβ, and corresponds, therefore, to T lymphocytes. This cell subset, which in rat is largely CD8 ϩ , mediates MHC non-restricted cytotoxicity after culture with IL-2 (52) .
At present, IL-2 seems to be a dispensable cytokine for the intrathymic maturation of murine T cell precursors, based on the analysis of IL-2-and IL-2R-deficient strains (27) (28) (29) , although previously both in vivo (5, 20, 21, 25) and in vitro (4, 9, 19, (22) (23) (24) approaches pointed out an important role for IL-2 in mouse T cell development. Nevertheless, it remains to be proven whether this conclusion can be extended to other species. On this regard, an involvement of IL-2 in human T cell maturation has been repeatedly reported (1, (16) (17) (18) 52, 53) . Also, CD25 expression on chicken embryonic thymocytes, following an analogous kinetics and distribution to that observed in mammals (2), suggests the existence of an IL-2-IL-2R-dependent pathway of thymocyte differentiation. Finally, our present findings provide evidence that the IL-2-IL-2R pathway is involved in rat T cell development during thymus ontogeny, and could be necessary for the expansion of early immature TN cells which later differentiate into DP and SP mature T lymphocytes. Likewise, IL-2 also plays an important role in the expansion affecting mature thymocytes around birth, as well as in the proliferation of γδ T cells and the intrathymic differentiation of rat NK cells.
